Global and Europe Insulin Glargine Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global Insulin Glargine market was valued at XX.0 million US$ in 2018, with the CAGR of 4.7%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Insulin Glargine market. Describe product range of Insulin Glargine, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Insulin Glargine market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Insulin Glargine market.

     

    By Player

    • Sanofi-Aventis

    • Ganlee

    • Biocon

    By Type

    • Single Dose Vial

    • Pre-filled Syringe

    By End-User

    • Treat type 1 diabetes

    • Treat type 2 diabetes

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Insulin Glargine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Insulin Glargine Market Size and Growth Rate of Single Dose Vial from 2014 to 2026

      • 1.3.2 Global Insulin Glargine Market Size and Growth Rate of Pre-filled Syringe from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Insulin Glargine Market Size and Growth Rate of Treat type 1 diabetes from 2014 to 2026

      • 1.4.2 Global Insulin Glargine Market Size and Growth Rate of Treat type 2 diabetes from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Insulin Glargine Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Insulin Glargine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Insulin Glargine by Major Types

      • 3.4.1 Insulin Glargine Market Size and Growth Rate of Single Dose Vial

      • 3.4.2 Insulin Glargine Market Size and Growth Rate of Pre-filled Syringe

    4 Segmentation of Insulin Glargine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Insulin Glargine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Insulin Glargine for Treat type 1 diabetes

      • 4.4.2 Market Size and Growth Rate of Insulin Glargine for Treat type 2 diabetes

    5 Market Analysis by Major Regions

    • 5.1 Global Insulin Glargine Production Analysis by Top Regions

    • 5.2 Global Insulin Glargine Consumption Analysis by Top Regions

    • 5.3 Global Insulin Glargine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Insulin Glargine Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Insulin Glargine Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Insulin Glargine Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Insulin Glargine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Insulin Glargine Market among Top Countries

    • 6.1 Top 5 Export Countries in Insulin Glargine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Insulin Glargine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Insulin Glargine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Insulin Glargine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Insulin Glargine Landscape Analysis

    • 7.1 North America Insulin Glargine Landscape Analysis by Top Countries

      • 7.1.1 United States Insulin Glargine Market Volume and Growth Rate

      • 7.1.2 Canada Insulin Glargine Market Volume and Growth Rate

      • 7.1.3 Mexico Insulin Glargine Market Volume and Growth Rate

    8. Europe Insulin Glargine Landscape Analysis

    • 8.1 Europe Insulin Glargine Landscape Analysis by Major Types

    • 8.2 Europe Insulin Glargine Landscape Analysis by Major End-Users

    • 8.3 Europe Insulin Glargine Landscape Analysis by Top Countries

      • 8.3.1 Germany Insulin Glargine Market Volume and Growth Rate

      • 8.3.2 UK Insulin Glargine Market Volume and Growth Rate

      • 8.3.3 France Insulin Glargine Market Volume and Growth Rate

      • 8.3.4 Italy Insulin Glargine Market Volume and Growth Rate

      • 8.3.5 Spain Insulin Glargine Market Volume and Growth Rate

      • 8.3.6 Belgium Insulin Glargine Market Volume and Growth Rate

      • 8.3.7 Poland Insulin Glargine Market Volume and Growth Rate

      • 8.3.8 Russia Insulin Glargine Market Volume and Growth Rate

      • 8.3.9 Turkey Insulin Glargine Market Volume and Growth Rate

      • 8.3.10 Netherlands Insulin Glargine Market Volume and Growth Rate

      • 8.3.11 Portugal Insulin Glargine Market Volume and Growth Rate

      • 8.3.12 Denmark Insulin Glargine Market Volume and Growth Rate

      • 8.3.13 Finland Insulin Glargine Market Volume and Growth Rate

      • 8.3.14 Iceland Insulin Glargine Market Volume and Growth Rate

      • 8.3.15 Norway Insulin Glargine Market Volume and Growth Rate

      • 8.3.16 Sweden Insulin Glargine Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Insulin Glargine Landscape Analysis

    • 9.1 Asia Pacific Insulin Glargine Landscape Analysis by Top Countries

      • 9.1.1 China Insulin Glargine Market Volume and Growth Rate

      • 9.1.2 Japan Insulin Glargine Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Insulin Glargine Market Volume and Growth Rate

      • 9.1.4 India Insulin Glargine Market Volume and Growth Rate

      • 9.1.5 ASEAN Insulin Glargine Market Volume and Growth Rate

      • 9.1.6 South Korea Insulin Glargine Market Volume and Growth Rate

    10 LAMEA Insulin Glargine Landscape Analysis

    • 10.1 LAMEA Insulin Glargine Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Insulin Glargine Market Volume and Growth Rate

      • 10.1.2 Brazil Insulin Glargine Market Volume and Growth Rate

      • 10.1.3 North Africa Insulin Glargine Market Volume and Growth Rate

      • 10.1.4 South Africa Insulin Glargine Market Volume and Growth Rate

      • 10.1.5 Argentina Insulin Glargine Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Sanofi-Aventis

      • 11.1.1 Sanofi-Aventis Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Ganlee

      • 11.2.1 Ganlee Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Biocon

      • 11.3.1 Biocon Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 119 Figures and 193 Tables)

    • Figure Product Picture

    • Figure Insulin Glargine Market Size and Growth Rate of Single Dose Vial from 2014 to 2026

    • Figure Insulin Glargine Market Size and Growth Rate of Pre-filled Syringe from 2014 to 2026

    • Figure Global Insulin Glargine Market Size and Growth Rate of Treat type 1 diabetes from 2014 to 2026

    • Figure Global Insulin Glargine Market Size and Growth Rate of Treat type 2 diabetes from 2014 to 2026

    • Figure North America Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure United States Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure France Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure China Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure India Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Insulin Glargine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Insulin Glargine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Insulin Glargine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Insulin Glargine by Different Types from 2014 to 2026

    • Table Consumption Share of Insulin Glargine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Single Dose Vial

    • Figure Market Size and Growth Rate of Pre-filled Syringe

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Insulin Glargine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Insulin Glargine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Treat type 1 diabetes

    • Figure Market Size and Growth Rate of Treat type 2 diabetes

    • Table Global Insulin Glargine Production by Major Regions

    • Table Global Insulin Glargine Production Share by Major Regions

    • Table Global Insulin Glargine Consumption by Major Regions

    • Table Global Insulin Glargine Consumption Share by Major Regions

    • Table North America Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table Europe Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table LAMEA Insulin Glargine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Insulin Glargine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Insulin Glargine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Insulin Glargine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table North America Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Insulin Glargine Consumption Share by Major Countries in 2014

    • Figure North America Insulin Glargine Consumption Share by Major Countries in 2018

    • Figure North America Insulin Glargine Consumption Share by Major Countries in 2026

    • Figure United States Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Insulin Glargine Consumption by Types from 2014 to 2026

    • Table Europe Insulin Glargine Consumption Share by Types from 2014 to 2026

    • Table Europe Insulin Glargine Consumption by End-Users from 2014 to 2026

    • Table Europe Insulin Glargine Consumption Share by End-Users from 2014 to 2026

    • Table Europe Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table Europe Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure France Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure China Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure India Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Insulin Glargine Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Insulin Glargine Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Insulin Glargine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Sanofi-Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis

    • Table Product and Service Introduction of Sanofi-Aventis

    • Table Company Profile and Development Status of Ganlee

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ganlee

    • Figure Sales and Growth Rate Analysis of Ganlee

    • Figure Revenue and Market Share Analysis of Ganlee

    • Table Product and Service Introduction of Ganlee

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.